sarepta.com - SRPT Company profit before taxes, interest and amortization

Public company logo of sarepta.com (SRPT)

Sarepta Therapeutics, Inc. (SRPT) dominates the treatment of rare muscle pathologies, establishing market prices through exclusive authorizations. Its leadership status in gene therapy is secured by patents and the complexity of RNA synthesis, which blocks the entry of generics. The EBITDA confirms operational strength, where 40.53 describes the current status of the metric. Business flexibility is supported by the outsourcing of production and clinical trials.

SRPT Sarepta Corp: Operating profit before deduction of amortization in the range 11/23/2025 - 11/17/2026

Sarepta Therapeutics Inc (SRPT) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Summary company analytics:Sarepta Therapeutics, Inc.
Product sample of Sarepta Therapeutics

This indicator measures daily cash flow from core operations, adjusted for the impact of depreciation and interest. The calculation is based on the difference between operating revenue and current business maintenance costs. Analyzing the EBITDA metric allows for the identification of hidden operational failures. For Sarepta Therapeutics, Inc. (SRPT), this trend confirms the monetization of its patent monopoly in gene therapy. High barriers to entry ensure stable profit growth.

Competitors of Sarepta Therapeutics, Inc. (SRPT)

Operating income before deduction of amortization Tempus AI Inc (TEM)|QGEN - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization IONS (Ionis Pharmaceuticals, Inc.)|RGEN: Operating profit EBITDA|Avidity - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization CRSP|Profit before interest, taxes and amortization genedx.com WGS|Operating profit before deduction of amortization RARE (Ultragenyx Corp)|BEAM (Beam Therapeutics) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Twist Bioscience Corp TWST|Operating income before deduction of amortization 10x Genomics, Inc. (TXG)|Intellia Therapeutics - Operating profit EBITDA|STOK - Operating profit EBITDA|BLFS (biolifesolutions.com) - Operating profit before deduction of amortization|WVE - Operating income before deduction of amortization|Operating profit before deduction of amortization MAZE|Sionna Pharma - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA PRME|TSHA (Taysha Gene Therapies) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization uniQure QURE|MGTX: Operating profit before amortization|REGENXBIO Inc - Operating profit EBITDA|Profit before interest, taxes and amortization Solid Corp|Ocugen (OCGN) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Pacific Biosciences|Operating profit before deduction of amortization BNTC|Operating profit before deduction of amortization Design Therapeutics Inc (DSGN)|Operating profit EBITDA RCKT|Operating profit EBITDA 4D Molecular Therapeutics, Inc. (FDMT)|lexeotx.com - Operating profit before deduction of amortization|KRRO: Operating profit before amortization|Editas Corp - Operating profit EBITDA|SLN: Profit before payment of interest, taxes and amortization|PRQR (ProQR) - Operating profit before deduction of amortization|Operating profit before amortization CDXS|Profit before payment of interest, taxes and amortization sangamo.com|Operating profit before amortization NAUT (Nautilus Biotechnology)|Operating profit EBITDA MGX|Operating income before deduction of amortization Precision BioSciences Inc.|Operating profit EBITDA GBIO (Generation Bio Co)|Operating profit EBITDA Boundless Bio, Inc BOLD|Exicure Corp - Operating profit EBITDA|Operating income before deduction of amortization Imunon IMNN|PHIO: Operating profit EBITDA|MBIO: Company profit before taxes, interest and amortization|Profit before payment of interest, taxes and amortization TransCode Therapeutics, Inc.|Operating profit EBITDA Bionano Genomics, Inc.|Profit before payment of interest, taxes and amortization Applied DNA (APDN)|Profit before payment of interest, taxes and amortization BLUE (bluebird bio, Inc.)|Operating profit EBITDA IPA (immunoprecise.com)|Operating profit EBITDA Omega OMGA|OMIC - Profit before payment of interest, taxes and amortization|RGLS - Operating profit EBITDA|Syros Pharmaceuticals Inc. (SYRS) - Profit before payment of interest, taxes and amortization|TBIO (Telesis Bio, Inc.) - Profit before payment of interest, taxes and amortization|TCON (TRACON Pharmaceuticals Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Unity Bio UBX